Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CU-T12-9
Cat. No.:
OB0425LY-035
Appearance:
Solid
Purity:
98.94%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
CU-T12-9 is a specific TLR1/2 agonist that activates both the innate and the adaptive immune systems.
Synonyms:
1821387-73-8; N-Methyl-4-nitro-2-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)aniline; N-Methyl-4-nitro-2-[4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]aniline; 1-(2-Methylamino-5-nitrophenyl)-4-(4-trifluoro-methylphenyl)-1H-imidazole
CAS No.:
1821387-73-8
Compound CID:
91826088
Formula:
C17H13F3N4O2
Formula Weight:
362.31
Specification
Target:
Toll-like receptor (TLR)
Pathway:
Immunology/Inflammation
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
CU-T12-9 can be used in basic biology research to explore cell signaling pathways.
